Peter F. Orio III, DO, MS, presented “Update on the State of the Art Radiation Treatments for Prostate Cancer” during the 24th Future Directions in Urology Symposium in August 2024 in Colorado Springs, Colorado.
How to cite: Orio III, Peter F. “Update on the State of the Art Radiation Treatments for Prostate Cancer.” August 2024. Accessed Apr 2026. https://grandroundsinurology.com/update-on-the-state-of-the-art-radiation-treatments-for-prostate-cancer/
Update on the State of the Art Radiation Treatments for Prostate Cancer – Summary
Peter F. Orio III, DO, MS, discusses radiation oncology for localized prostate cancer. He focuses on a range of advanced techniques aimed at delivering high-dose radiation to the tumor while minimizing toxicity to surrounding tissues. Key modalities include Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiation Therapy (SBRT), and adaptive radiation therapy, each providing distinct advantages in precision and dose management.
Dr. Orio discusses emerging technologies like MR-guided linear accelerators (MR-Linacs), and controversial options like proton therapy and prostate brachytherapy. He also addresses evolving advanced radiation techniques, with artificial intelligence growing in treatment planning and execution.
Despite these advances, ongoing research is necessary to validate the clinical benefits of these technologies and ensure they effectively reduce toxicity and improve patient outcomes. The overarching goal remains to provide personalized, precision radiation therapy that maximizes tumor control while minimizing harm to patients.
The Future Directions in Urology Symposium (FDUS) is an annual urology think tank and non-CME educational summit that brings together industry figures and experts to discuss the current state of genitourinary care and define future directions in treatment. Dr. Dreicer delivered this educational activity during the 24th iteration of the meeting in August 2024 in Colorado Springs, Colorado.
ABOUT THE AUTHOR
Peter F. Orio III, DO, MS, FABS, FASTRO, is Chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute and an associate professor at Harvard Medical School, in Boston, Massachusetts. He previously served as the Vice Chair of Network Operations for Radiation Oncology at the Dana-Farber Cancer Institute, where he guided the growth of the department to ensure high-quality care through the standardization of clinical practice, program implementation, and staff mentoring.
